Sample Size and Power for Cost-Effectiveness Analysis (Part 2) The Effect of Maximum Willingness to Pay

被引:12
作者
Glick, Henry A. [1 ,2 ]
机构
[1] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA
[2] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA
关键词
LIFE;
D O I
10.2165/11585080-000000000-00000
中图分类号
F [经济];
学科分类号
02 ;
摘要
Sample size and power for cost-effectiveness analysis depend on assumptions about the difference in cost and effect, the standard deviations of cost and effect, the correlation of the difference in cost and effect, the alpha and beta errors and maximum willingness to pay (W). The first seven of these parameters share much in common in their effect on sample size and power for cost-effectiveness analysis, including that each is associated with a single pattern of power. W, on the other hand, is unique in that, when plotted for positive values, we can potentially observe any of six patterns of power associated with positive values of W. In addition, as W approaches infinity, power need be neither monotonically increasing nor decreasing and it can be multi-modal. In this article, the relationship between W and sample size and power is explained.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 7 条
[1]   LIFE IN THE BALANCE [J].
Cressey, Daniel .
NATURE, 2009, 461 (7262) :336-339
[2]   Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation [J].
Dedes, Konstantin J. ;
Matter-Walstra, Klazien ;
Schwenkglenks, Matthias ;
Pestalozzi, Bernhard C. ;
Fink, Daniel ;
Brauchli, Peter ;
Szucs, Thomas D. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) :1397-1406
[3]   Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J].
Devlin, N ;
Parkin, D .
HEALTH ECONOMICS, 2004, 13 (05) :437-452
[4]   Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge? [J].
Eichler, HG ;
Kong, SX ;
Gerth, WC ;
Mavros, P ;
Jönsson, B .
VALUE IN HEALTH, 2004, 7 (05) :518-528
[5]  
GLICK HA, PHARMACOECONOMICS
[6]  
Glick HA., 2007, Economic Evaluation in Clinical Trials
[7]   What is the price of life and why doesn't it increase at the rate of inflation? [J].
Ubel, PA ;
Hirth, RA ;
Chernew, ME ;
Fendrick, AM .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (14) :1637-1641